Around 100 Pakistani heart patients have died after taking faulty medicine made locally and dozens more are in a critical condition in hospital, government officials said yesterday. "Nearly 100 patients have died due to a reaction to heart drugs," said Shahbaz Sharif, the head of the government in central Punjab province. The victims were mostly poor patients who received free drugs from the state- run Punjab Institute of Cardiology (PIC), he said. The government said another 287 people had been admitted to hospitals in Lahore, Pakistan's second largest city, after taking the drugs. Police have arrested owners of three pharmaceutical companies suspected of supplying the medicine. "Police registered a case on Tuesday after reports of deaths of people due to reaction of drugs for cardiovascular diseases," police spokesman Haroon Rashid said. Initial investigations show that drugs supplied by local manufacturers were "sub-standard," police said. The patients died due to a sudden drop in white blood cells, platelets and bone marrow damage. The problem was first detected in December when contaminated drugs in at least one batch of medicine caused 23 deaths. Sharif said samples of the suspect drugs have been sent to laboratories for tests in Pakistan, London and Paris. "Action will be taken against those found guilty," he said. The medicine has since been removed from hospitals and stores.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor